MedPath

浙江国光生物制药股份有限公司

Ownership
-
Established
1996-06-17
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

34

NMPA:34

Drug Approvals

Famciclovir Tablets

Product Name
泛昔洛韦片
Approval Number
国药准字H20094067
Approval Date
Jul 31, 2024
NMPA

Famciclovir Tablets

Product Name
泛昔洛韦片
Approval Number
国药准字H20094068
Approval Date
Jul 31, 2024
NMPA

Inosine Oral Solution

Product Name
肌苷口服液
Approval Number
国药准字H36022404
Approval Date
Oct 28, 2020
NMPA

Paracetamol Oral Solution

Product Name
对乙酰氨基酚口服溶液
Approval Number
国药准字H36022269
Approval Date
Oct 28, 2020
NMPA

银翘解毒合剂

Approval Number
国药准字Z36021333
Approval Date
Jun 12, 2020
NMPA

脑心舒口服液

Approval Number
国药准字Z36021326
Approval Date
Jun 12, 2020
NMPA

健儿清解液

Approval Number
国药准字Z36021324
Approval Date
Jun 12, 2020
NMPA

川贝枇杷糖浆

Approval Number
国药准字Z36021320
Approval Date
Jun 12, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H33020891
Approval Date
Jun 12, 2020
NMPA

强力枇杷露

Approval Number
国药准字Z36021327
Approval Date
Jun 12, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.